DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,003,000 | +2.5% | 4,041 | -1.0% | 0.12% | +9.3% |
| Q2 2023 | $979,000 | +7.3% | 4,080 | +12.7% | 0.11% | +0.9% |
| Q1 2023 | $912,000 | -7.6% | 3,620 | -2.7% | 0.11% | -10.2% |
| Q4 2022 | $987,000 | +2.7% | 3,720 | 0.0% | 0.12% | -9.9% |
| Q3 2022 | $961,000 | +1.9% | 3,720 | 0.0% | 0.13% | +5.6% |
| Q2 2022 | $943,000 | -15.9% | 3,720 | -2.6% | 0.12% | -0.8% |
| Q1 2022 | $1,121,000 | -10.8% | 3,820 | 0.0% | 0.12% | -8.8% |
| Q4 2021 | $1,257,000 | +8.1% | 3,820 | 0.0% | 0.14% | -2.1% |
| Q3 2021 | $1,163,000 | +11.7% | 3,820 | -1.5% | 0.14% | +15.7% |
| Q2 2021 | $1,041,000 | +19.2% | 3,880 | 0.0% | 0.12% | +14.2% |
| Q1 2021 | $873,000 | +1.3% | 3,880 | 0.0% | 0.11% | -7.0% |
| Q4 2020 | $862,000 | -4.2% | 3,880 | -7.2% | 0.11% | -15.6% |
| Q3 2020 | $900,000 | +21.8% | 4,180 | 0.0% | 0.14% | +12.5% |
| Q2 2020 | $739,000 | +26.3% | 4,180 | -1.1% | 0.12% | +2.6% |
| Q1 2020 | $585,000 | -9.7% | 4,225 | 0.0% | 0.12% | +23.2% |
| Q4 2019 | $648,000 | +6.2% | 4,225 | 0.0% | 0.10% | +1.1% |
| Q3 2019 | $610,000 | +1.0% | 4,225 | 0.0% | 0.09% | +4.4% |
| Q2 2019 | $604,000 | +8.2% | 4,225 | 0.0% | 0.09% | +8.4% |
| Q1 2019 | $558,000 | +24.8% | 4,225 | -2.6% | 0.08% | +13.7% |
| Q4 2018 | $447,000 | -2.8% | 4,336 | +2.4% | 0.07% | +12.3% |
| Q3 2018 | $460,000 | +12.7% | 4,236 | +2.4% | 0.06% | +10.2% |
| Q2 2018 | $408,000 | +4.1% | 4,136 | +3.4% | 0.06% | +1.7% |
| Q1 2018 | $392,000 | +5.4% | 4,001 | 0.0% | 0.06% | +11.5% |
| Q4 2017 | $372,000 | +8.5% | 4,001 | 0.0% | 0.05% | +4.0% |
| Q3 2017 | $343,000 | +1.5% | 4,001 | 0.0% | 0.05% | -3.8% |
| Q2 2017 | $338,000 | -1.5% | 4,001 | 0.0% | 0.05% | +2.0% |
| Q1 2017 | $343,000 | +2.4% | 4,001 | -2.7% | 0.05% | -7.3% |
| Q4 2016 | $335,000 | 0.0% | 4,111 | 0.0% | 0.06% | 0.0% |
| Q3 2016 | $335,000 | -19.3% | 4,111 | 0.0% | 0.06% | -22.5% |
| Q2 2016 | $415,000 | -30.1% | 4,111 | -34.3% | 0.07% | -33.0% |
| Q1 2016 | $594,000 | +1.5% | 6,261 | -0.6% | 0.11% | +1.9% |
| Q4 2015 | $585,000 | +10.0% | 6,296 | +0.8% | 0.10% | -4.6% |
| Q3 2015 | $532,000 | +0.4% | 6,246 | +0.8% | 0.11% | +11.2% |
| Q2 2015 | $530,000 | +25.6% | 6,196 | +24.6% | 0.10% | +32.4% |
| Q1 2015 | $422,000 | +55.7% | 4,971 | +57.3% | 0.07% | +57.4% |
| Q4 2014 | $271,000 | +22.1% | 3,161 | +8.2% | 0.05% | +17.5% |
| Q3 2014 | $222,000 | +8.3% | 2,921 | +12.1% | 0.04% | +5.3% |
| Q2 2014 | $205,000 | – | 2,606 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |